INNOVATIONS IN HEALTHCARE: MEASURES TO SUPPORT INNOVATIONS AND OPPORTUNITIES FOR THEIR ACCELERATED INTRODUCTION BASED ON THE EXPERIENCE OF RUSSIA AND CHINA

One of the key indicators of Russia’s competitiveness is the extent of the development of its innovation and healthcare sectors. The National Security Strategy envisages the introduction of incentives by the government, the encouragement of private investment in innovative activities, and the accelerated introduction of their results to ensure the sustainable growth of the Russian economy. Russia has significant potential in terms of fundamental and applied research, an extensive system of scientific and educational centres, and advantages in a number of technologies. One of the tasks that is crucial to achieving the country’s goals of scientific and technological development is the creation of instruments to protect intellectual property and the expanded enforcement of patent legislation in order to get Russian businesses more interested in developing innovative activities. The development and introduction of new medical technologies and medicines is also pivotal to Russia’s healthcare strategy, including the creation of centralized digital platforms to diagnose diseases using artificial intelligence, the introduction of modern molecular genetic methods to forecast, diagnose, and monitor the progression of diseases, personalized pharmacotherapy methods, as well as numerous other existing and emerging technologies of the future. The strategy of supporting innovative developments has also been crucial to China’s success in recent decades in transforming the economy from a global producer of knowledge-intensive technological goods to a developer and pioneer in multiple fields of science. Some of the key features of the approach taken by Chinese innovative developers include their focus on the applied use of new technologies, the broad mobility and speed of decision-making, significant and diversified government support for innovators, as well as a focus on introducing new technologies equally in the local and foreign markets. What measures are most effective and essential to support the development and introduction of innovations? What regulatory conditions are needed to create the most conducive innovation ecosystem? What barriers to innovation have been encountered and still need to be addressed? How can innovation in healthcare be accelerated? What is the best way to gain international recognition in the context of intercountry competition for human capital, sales markets, and scientific leadership?